Shock wave treatment induces angiogenesis and mobilizes endogenous CD31/CD34-positive endothelial cells in a hindlimb ischemia model: Implications for angiogenesis and vasculogenesis - Tepeköylü, Can; Wang, Feng-Sheng; Kozaryn, Radoslaw; Albrecht-Schgoer, Karin; Theurl, Markus; Schaden, Wolfgang; Ke, Huei-Jin; Yang, Yaju; Kirchmair, Rudolf; Grimm, Michael; Wang, Ching-Jen; Holfeld, Johannes (The Journal of thoracic and cardiovascular surgery, 2013)
Keywords: Animals; Antigens, CD34 - metabolism; Biomarkers - metabolism; Cardiothoracic Surgery; Cell Movement; Chemokine CXCL12 - genetics; Chemokine CXCL12 - metabolism; Disease Models, Animal; Endothelial Cells - metabolism; High-Energy Shock Waves - therapeutic use; Hindlimb; Hypoxia-Inducible Factor 1, alpha Subunit - genetics; Hypoxia-Inducible Factor 1, alpha Subunit - metabolism; Ischemia - genetics; Ischemia - metabolism; Ischemia - physiopathology; Ischemia - therapy; Muscle, Skeletal - blood supply; Neovascularization, Physiologic; Platelet Endothelial Cell Adhesion Molecule-1 - metabolism; Rats; Rats, Sprague-Dawley; Receptors, CXCR4 - genetics; Receptors, CXCR4 - metabolism; Recovery of Function; Regional Blood Flow; Time Factors; Vascular Endothelial Growth Factor A - genetics; Vascular Endothelial Growth Factor A - metabolism; CTR; Ct; SWT; 39.2; PCNA; 39.4; VEGF; SDF-1; EPC; HIF-1α; hypoxia-inducible factor 1α; shock wave therapy; cycle threshold; endothelial progenitor cell; control; proliferating cell nuclear antigen; vascular endothelial growth factor; stromal cell-derived factor-1